Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
Stock
TARS
TARS News & Events
-
Add to Watchlist
Trade TARS
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Forecast
Technical
Valuation
Financials
Earnings
Should I Buy
News
TARS News
From Olema to Insmed: Do These Soaring Biotechs Still Present a Good Investment Opportunity?
Nov 19 2025
NASDAQ.COM
Tarsus Pharmaceuticals, Inc. (TARS) Posts Q3 Loss but Exceeds Revenue Projections
Nov 05 2025
NASDAQ.COM
Tarsus Sets Q4 Sales Goal of $140M–$145M Amidst Increased XDEMVY Adoption and Pipeline Development
Nov 04 2025
SeekingAlpha
HC Wainwright & Co. Reaffirms Buy Rating for Tarsus Pharmaceuticals and Increases Price Target to $88
Oct 20 2025
Benzinga
Noteworthy TARS Put and Call Options Set for November 21st
Sep 19 2025
NASDAQ.COM
Tarsus Set to Join Upcoming Investor Conferences
Aug 27 2025
Newsfilter
Two Health Care Stocks at Risk of Significant Decline This August
Aug 20 2025
Benzinga
Frazier Life Sciences Closes Oversubscribed $1.3 Billion Venture Fund
Jul 31 2025
Newsfilter
Show More News
TARS Events
No data
TARS Monitor News
No data
TARS Earnings Analysis
No Data
People Also Watch
